chronic migraineCMatogepantBTX-ATOATOm
…elevance Results suggest that the effectiveness of atogepant in chronic migraine, in terms of reducing monthly migraine days, is comparable betw…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 4,861–4,920 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
unexplained subfertility2unruptured intracranial aneurysm2unruptured intracranial aneurysms (UIAs)2upper GI bleeding2upper gastrointestinal cancer2upper respiratory tract infection2ureteropelvic junction obstruction2urinary retention2urothelial cancers2uterine leiomyoma2uterine prolapse2uterine sarcoma2vaginal dryness2varicella zoster infection2vascular leak syndrome2vascular malformations2vector-borne diseases2venous outflow obstruction2ventricular arrhythmia2ventricular dyssynchrony2viral pneumonia2viral respiratory infections2walled-off necrosis2wet Age-Related macular degeneration2wound infection2β-thalassaemia major2severe MASLD1ankyloglossia1dMMR/MSI-H1TAs1SAPHO1iPE1HPV-positive OPC1LN-CKD1Acute obstetric coagulopathy1GBM431ANCA-CKD1Incident cancer1dMMR/MSI-H CRC1full-course DR1CA-A11SCCis1hMPV1BCG-unresponsive CIS1BCG-unresponsive NMIBC1OPC1VTDR1drug sensitive TB1excess adiposity1radicular syndromes1AMEN1Exomphalos1PHOMS1TMB-high1BPD-PH1BPaL1M tuberculosis1NSIGC1cardiac inflammation1dMMR/MSI-H colon cancer1
Articles mentioning diseases
23,712 articles · page 401 of 1976diabetic macular oedemaneovascular age-related macular degenerationnAMDDMEfaricimabranibizumabafliberceptbrolucizumab
…ment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME). Unlike previous anti-VEGF agents, faricimab targets both…
hepatic impairmentcirrhosishepatic insufficiencybeta-blockerssecondary care hospitalpsycholepticshypolipidemic agentsSociety of Hospital Pharmacists of Australia
…y, is limited. The adaptation of drug dosages in the context of hepatic impairment is a complex issue that lacks comprehensive discussion in curre…
ABSSSIosteomyelitisspondylodiscitisacute bacterial skin and skin structure infectionsprosthetic joint infectioncomplex infectionsdalbavancinAmbulatory consolidation therapyHospital Pharmacy Department
…odality. Off-label use was defined as any indication other than ABSSSI. A stepwise backward selection linear regression model was used…
acute severe hyperkalaemiachronic hyperkalaemiaacute hyperkalaemiarenal failurecalcium gluconateinsulinintravenous glucoseSZCtertiary hospital
…tiation.SZC appears to be an effective adjunctive treatment for acute severe hyperkalaemia in patients with renal failure who are already receiving standa…
migraineepisodic migraineatogepant
…ly approved oral calcitonin gene-related peptide antagonist for migraine prophylaxis in adults. Real-world data on its efficacy and safe…
multiple sclerosisMSSPMSRRMSofatumumabocrelizumabteriflunomidenatalizumab
… all patients with relapsing-remitting or secondary progressive multiple sclerosis (RRMS; SPMS), who initiated Ofatumumab between January 2023 and…
migraineCMAtogepantNeurology DepartmentEthics Committee
…ts calcitonin gene-related peptide (CGRP) receptors involved in migraine development.Aim and Objectives To evaluate atogepant effectiven…
diabetic macular oedemawet age-related macular degenerationDMEAMDAflibercept
…the treatment of wet age-related macular degeneration (AMD) and diabetic macular oedema (DME) in adults.Aim and Objectives To evaluate the use of aflib…
aGVHDaGVHD-cumulative-incidenceacute renal failureacute graft-versus-host diseaseaGVHD-relatedaGVHD-freeEuropean Society for Blood and Marrow TransplantationPHARALLOEBMT
…luded (37 intervention; 30 control).The cumulative incidence of aGVHD by day +100 was reduced by 13.4% in the intervention group (p=0…
Rheumatoid arthritisRAErelziBenepaliEnbrel
…Background and Importance Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic joint disease. Although…
migraineHeadacheCGRPgalcanezumaberenumabfremanezumab
…, anti-CGRP mAbs were associated with significant reductions in migraine frequency after 6 months. Galcanezumab showed the greatest mean…